High Efficacy and Safety of VTD as an Induction Protocol in Newly Diagnosed Mm Patients Eligible for HDT/Autosct – A Report of Polish Multiple Myeloma Study Group

Abstract

Conclusions: MRD by MFC is sensitive technique and should be feasible at a relatively low cost (<50 USD) in most state-funded hospitals in India. In our hands, it had a better sensitivity than SPE and IFX in assessing residual disease, and we propose its routine incorporation in monitoring of MM. Although, we could not demonstrate difference in overall and progression-free survival based on MRD status, it is understandable that a longer follow up and upgradation to 8 to 10 colour flow with increased sensitivity of MRD detection would be able to show more realistic outcomes.